Published in Lancet Infect Dis on June 01, 2007
Liver Fibrosis in Zambian HIV-HBV Co-infected Patients | NCT02344680
Hepatitis B virus infection and response to antiretroviral therapy (ART) in a South African ART program. Clin Infect Dis (2008) 2.32
Hepatitis B, Hepatitis C and HIV-1 Coinfection in Two Informal Urban Settlements in Nairobi, Kenya. PLoS One (2015) 1.53
Hepatitis B and Delta virus are prevalent but often subclinical co-infections among HIV infected patients in Guinea-Bissau, West Africa: a cross-sectional study. PLoS One (2014) 1.43
Chronic viral hepatitis: policy, regulation, and strategies for its control and elimination in Ethiopia. BMC Public Health (2016) 1.38
HIV-HBV coinfection--a global challenge. N Engl J Med (2012) 1.36
Viral hepatitis and rapid diagnostic test based screening for HBsAg in HIV-infected patients in rural Tanzania. PLoS One (2013) 1.21
High seroprevalence of HBV and HCV infection in HIV-infected adults in Kigali, Rwanda. PLoS One (2013) 1.16
Disparities and risks of sexually transmissible infections among men who have sex with men in China: a meta-analysis and data synthesis. PLoS One (2014) 1.05
Chronic hepatitis B: management challenges in resource-poor countries. Hepat Mon (2011) 1.03
Impaired quality of the hepatitis B virus (HBV)-specific T-cell response in human immunodeficiency virus type 1-HBV coinfection. J Virol (2009) 0.99
HIV/HBV Co-Infections: Epidemiology, Natural History, and Treatment: A Review Article. Iran Red Crescent Med J (2011) 0.95
Viral hepatitis in resource-limited countries and access to antiviral therapies: current and future challenges. Future Virol (2013) 0.94
Patterns and causes of suboptimal response to tenofovir-based therapy in individuals coinfected with HIV and hepatitis B virus. Clin Infect Dis (2013) 0.93
Hepatitis B virus coinfection in human immunodeficiency virus-infected patients: a review. World J Gastroenterol (2014) 0.93
Child-Pugh-Turcott versus Meld score for predicting survival in a retrospective cohort of black African cirrhotic patients. World J Gastroenterol (2008) 0.92
Hepatitis B and/or C co-infection in HIV infected patients: a study in a tertiary care centre from South India. Indian J Med Res (2013) 0.92
HIV and co-infections. Immunol Rev (2013) 0.92
Prevalence, clinical and virologic outcomes of hepatitis B virus co-infection in HIV-1 positive Kenyan women on antiretroviral therapy. PLoS One (2013) 0.91
High prevalence of HBsAg during pregnancy in Asian communities at Cayenne Hospital, French Guiana. Am J Trop Med Hyg (2010) 0.90
The role of co-infections in mother-to-child transmission of HIV. Curr HIV Res (2013) 0.90
Hepatitis B virus sub-genotype A1 infection is characterized by high replication levels and rapid emergence of drug resistance in HIV-positive adults receiving first-line antiretroviral therapy in Malawi. Clin Infect Dis (2014) 0.89
Hepatotoxicity and effectiveness of a Nevirapine-based antiretroviral therapy in HIV-infected patients with or without viral hepatitis B or C infection in Cameroon. BMC Public Health (2010) 0.89
Liver microRNA hsa-miR-125a-5p in HBV chronic infection: correlation with HBV replication and disease progression. PLoS One (2013) 0.89
Hepatitis B and C co-infection among HIV-infected adults while on antiretroviral treatment: long-term survival, CD4 cell count recovery and antiretroviral toxicity in Cambodia. PLoS One (2014) 0.88
Seroprevalence of HBV, HCV & HIV co-infection and risk factors analysis in Tripoli-Libya. PLoS One (2014) 0.87
Prevalence and associations with hepatitis B and hepatitis C infection among HIV-infected adults in South Africa. Int J STD AIDS (2012) 0.87
Hepatitis B and human immunodeficiency virus co-infection. World J Gastroenterol (2014) 0.86
Hepatitis B Co-Infection is Associated with Poorer Survival of HIV-Infected Patients on Highly Active Antiretroviral Therapy in West Africa. J AIDS Clin Res (2013) 0.85
Natural killer cell functional dichotomy: a feature of chronic viral hepatitis? Front Immunol (2012) 0.85
Hepatitis B virus / human immunodeficiency virus co-infection and its hepatocarcinogenic potential in sub-saharan black africans. Hepat Mon (2012) 0.83
Prevalence and virological profiles of hepatitis B infection in human immunodeficiency virus patients. World J Hepatol (2012) 0.83
The epidemiology of hepatitis B virus infection in HIV-infected and HIV-uninfected pregnant women in the Western Cape, South Africa. Vaccine (2013) 0.82
Recent advances in micro/nanotechnologies for global control of hepatitis B infection. Biotechnol Adv (2014) 0.81
HIV-Infected or -Exposed Children Exhibit Lower Immunogenicity to Hepatitis B Vaccine in Yaoundé, Cameroon: An Appeal for Revised Policies in Tropical Settings? PLoS One (2016) 0.79
Maternal hepatitis B and infant infection among pregnant women living with HIV in South Africa. J Int AIDS Soc (2014) 0.79
Pediatric HIV-HBV Coinfection in Lusaka, Zambia: Prevalence and Short-Term Treatment Outcomes. J Trop Pediatr (2015) 0.79
Hepatitis B virus and HIV infection among patients with primary hepatocellular carcinoma in Kampala, Uganda. Afr Health Sci (2011) 0.79
Future directions in the treatment of HIV-HBV coinfection. HIV Ther (2009) 0.79
HIV and hepatitis B co-infection in Africa. Lancet Infect Dis (2008) 0.78
Co-infection of human immunodeficiency virus, hepatitis C and hepatitis B virus among injection drug users in Drop in centers. J Res Med Sci (2014) 0.78
Slow CD4(+) T-Cell Recovery in Human Immunodeficiency Virus/Hepatitis B Virus-Coinfected Patients Initiating Truvada-Based Combination Antiretroviral Therapy in Botswana. Open Forum Infect Dis (2016) 0.77
Hepatitis B and C Co-Infection in HIV Patients from the TREAT Asia HIV Observational Database: Analysis of Risk Factors and Survival. PLoS One (2016) 0.77
Chronic hepatitis B virus coinfection is associated with renal impairment among Zambian HIV-infected adults. Clin Infect Dis (2014) 0.77
Tuberculosis and hepatic steatosis are prevalent liver pathology findings among HIV-infected patients in South Africa. PLoS One (2015) 0.77
Impact of maternal hepatitis B virus coinfection on mother-to-child transmission of HIV. HIV Med (2014) 0.77
Viral hepatitis and human immunodeficiency virus co-infections in Asia. World J Virol (2015) 0.77
Access to treatment for HBV infection and its consistency with 2008 European guidelines in a multicentre cross-sectional study of HIV/HBV co-infected patients in Italy. BMC Res Notes (2013) 0.75
Insights into human immunodeficiency virus-hepatitis B virus co-infection in India. World J Virol (2015) 0.75
Effect of Hepatitis B Virus Co-Infection on CD4 Cell Count and Liver Function of HIV Infected Patients. Ghana Med J (2015) 0.75
Effect of hepatitis-B virus co-infection on CD4 cell count and liver function of HIV infected patients. Ghana Med J (2014) 0.75
Symptom Status Predicts Patient Outcomes in Persons with HIV and Comorbid Liver Disease. AIDS Res Treat (2012) 0.75
Mechanisms of Accelerated Liver Fibrosis Progression during HIV Infection. J Clin Transl Hepatol (2016) 0.75
Seroprevalence of hepatitis B, hepatitis C, human immunodeficiency virus, Treponema pallidum, and co-infections among blood donors in Kyrgyzstan: a retrospective analysis (2013-2015). Infect Dis Poverty (2017) 0.75
HBV genotypes and drug resistance mutations in antiretroviral treatment-naive and treatment-experienced HBV-HIV-coinfected patients. Antivir Ther (2016) 0.75
HBV influence on Response to Antiretroviral Therapy in Horizontally HIV-HBV Coinfected Patient during Early Childhood. Curr Health Sci J (2013) 0.75
Prevalence of Hepatitis B Co-Infection among HIV Positive Patients: Narrative Review Article. Iran J Public Health (2014) 0.75
Tenofovir-based antiretroviral therapy in HBV-HIV coinfection: results from the TREAT Asia HIV Observational Database. Antivir Ther (2015) 0.75
Occurrence of HBV/HIV coinfection by laboratory values in Roma, Lesotho. Germs (2015) 0.75
HBV/HIV co-infection and APOBEC3G polymorphisms in a population from Burkina Faso. BMC Infect Dis (2016) 0.75
Hepatitis B Virus Incidence and Risk Factors Among Human Immunodeficiency Virus-1 Negative Men Who Have Sex With Men in Kenya. Open Forum Infect Dis (2016) 0.75
Prevalence of hepatitis B and delta according to HIV-type: a multi-country cross-sectional survey in West Africa. BMC Infect Dis (2017) 0.75
A Comparison of Hepatitis B Virus Infection in HIV-infected and HIV-uninfected Participants Enrolled in a Multi-National Clinical Trial: HPTN 052. J Acquir Immune Defic Syndr (2017) 0.75
HBV infection in untreated HIV-infected adults in Maputo, Mozambique. PLoS One (2017) 0.75
Discrepancies in prevalence trends for HIV, hepatitis B virus, and hepatitis C virus in Haiphong, Vietnam from 2007 to 2012. PLoS One (2017) 0.75
Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature (2009) 13.99
HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science (2004) 8.22
The HBV drug entecavir - effects on HIV-1 replication and resistance. N Engl J Med (2007) 3.20
Hepatotoxicity in an African antiretroviral therapy cohort: the effect of tuberculosis and hepatitis B. AIDS (2007) 3.19
IL28B and the control of hepatitis C virus infection. Gastroenterology (2010) 3.02
Hepatitis B virus coinfection negatively impacts HIV outcomes in HIV seroconverters. J Infect Dis (2011) 2.86
Hepatitis B virus infection and response to antiretroviral therapy (ART) in a South African ART program. Clin Infect Dis (2008) 2.32
HIV monoinfection is associated with increased aspartate aminotransferase-to-platelet ratio index, a surrogate marker for hepatic fibrosis. J Infect Dis (2012) 2.30
Incident hepatitis C virus infection in men who have sex with men: a prospective cohort analysis, 1984-2011. Clin Infect Dis (2013) 2.15
Identification of IFRD1 as a modifier gene for cystic fibrosis lung disease. Nature (2009) 2.05
Genome-wide association study of spontaneous resolution of hepatitis C virus infection: data from multiple cohorts. Ann Intern Med (2013) 1.82
Treatment of chronic hepatitis B virus infection in resource-constrained settings: expert panel consensus. Liver Int (2011) 1.75
Characteristics of drug resistant HBV in an international collaborative study of HIV-HBV-infected individuals on extended lamivudine therapy. AIDS (2006) 1.52
Impact of hepatitis B virus infection on human immunodeficiency virus response to antiretroviral therapy in Nigeria. Clin Infect Dis (2009) 1.52
The anti-HIV activity of entecavir: a multicentre evaluation of lamivudine-experienced and lamivudine-naive patients. AIDS (2008) 1.50
IL28B polymorphism does not determine outcomes of hepatitis B virus or HIV infection. J Infect Dis (2010) 1.48
Hepatitis B and long-term HIV outcomes in coinfected HAART recipients. AIDS (2009) 1.39
Liver disease in the HIV-infected individual. Clin Gastroenterol Hepatol (2010) 1.33
Antiretroviral therapy using zidovudine, lamivudine, and efavirenz in South Africa: tolerability and clinical events. AIDS (2008) 1.32
Large-scale candidate gene analysis of spontaneous clearance of hepatitis C virus. J Infect Dis (2010) 1.28
Specific human leukocyte antigen class I and II alleles associated with hepatitis C virus viremia. Hepatology (2010) 1.28
A novel variant marking HLA-DP expression levels predicts recovery from hepatitis B virus infection. J Virol (2012) 1.24
A functional SNP of interferon-gamma gene is important for interferon-alpha-induced and spontaneous recovery from hepatitis C virus infection. Proc Natl Acad Sci U S A (2007) 1.24
Association of CTLA4 polymorphism with regulatory T cell frequency. Eur J Immunol (2005) 1.22
The relation of HLA genotype to hepatitis C viral load and markers of liver fibrosis in HIV-infected and HIV-uninfected women. J Infect Dis (2011) 1.13
Pre-steady-state kinetic studies establish entecavir 5'-triphosphate as a substrate for HIV-1 reverse transcriptase. J Biol Chem (2007) 1.07
Review of hepatitis B therapeutics. Clin Infect Dis (2010) 1.06
Genetic polymorphism in IL28B is associated with spontaneous clearance of hepatitis C virus genotype 4 infection in an Egyptian cohort. J Infect Dis (2011) 1.04
Regulatory polymorphisms in the interleukin-18 promoter are associated with hepatitis C virus clearance. J Infect Dis (2008) 1.03
KIR2DL2 enhances protective and detrimental HLA class I-mediated immunity in chronic viral infection. PLoS Pathog (2011) 1.02
Combination HBV therapy is linked to greater HBV DNA suppression in a cohort of lamivudine-experienced HIV/HBV coinfected individuals. AIDS (2009) 1.01
Gonorrhoea and chlamydia testing rates of HIV-infected men: low despite guidelines. Sex Transm Infect (2010) 0.97
Interleukin-28b: a key piece of the hepatitis C virus recovery puzzle. Gastroenterology (2010) 0.97
Evaluation of IL10, IL19 and IL20 gene polymorphisms and chronic hepatitis B infection outcome. Int J Immunogenet (2008) 0.96
Assessment of liver fibrosis by transient elastography in patients with HIV and hepatitis B virus coinfection in Nigeria. Clin Infect Dis (2013) 0.94
Patterns and causes of suboptimal response to tenofovir-based therapy in individuals coinfected with HIV and hepatitis B virus. Clin Infect Dis (2013) 0.93
HIV outcomes in Hepatitis B virus coinfected individuals on HAART. J Acquir Immune Defic Syndr (2014) 0.92
Increased gonorrhoea and chlamydia testing did not increase case detection in an HIV clinical cohort 1999-2007. Sex Transm Infect (2011) 0.90
Identification of a novel hepatitis B virus precore/core deletion mutant in HIV/hepatitis B virus co-infected individuals. AIDS (2007) 0.88
Tenofovir for the treatment of hepatitis B virus. Pharmacotherapy (2009) 0.84
Comparative risk of liver-related mortality from chronic hepatitis B versus chronic hepatitis C virus infection. Clin Infect Dis (2012) 0.84
Predictors of the isolated hepatitis B core antibody pattern in HIV-infected and -uninfected men in the multicenter AIDS cohort study. Clin Infect Dis (2012) 0.83
Incident Hepatitis B Virus Infection in HIV-Infected and HIV-Uninfected Men Who Have Sex With Men From Pre-HAART to HAART Periods: A Cohort Study. Ann Intern Med (2015) 0.83
Factors associated with delayed hepatitis B viral suppression on tenofovir among patients coinfected with HBV-HIV in the CNICS cohort. J Acquir Immune Defic Syndr (2014) 0.82
In vitro replication phenotype of a novel (-1G) hepatitis B virus variant associated with HIV co-infection. J Med Virol (2012) 0.81
Lamivudine Monotherapy-Based cART Is Efficacious for HBV Treatment in HIV/HBV Coinfection When Baseline HBV DNA <20,000 IU/mL. J Acquir Immune Defic Syndr (2016) 0.81
Liver disease, HIV and aging. Sex Health (2011) 0.80
A closer look at hepatitis C clearance in HIV controllers. AIDS (2014) 0.79
HBV mutations in untreated HIV-HBV co-infection using genomic length sequencing. Virology (2010) 0.79
False-negative hepatitis B virus (HBV) surface antigen in a vaccinated dialysis patient with a high level of HBV DNA in the United States. Clin Vaccine Immunol (2012) 0.78
Chronic hepatitis B: a critical appraisal of current approaches to therapy. Clin Gastroenterol Hepatol (2006) 0.78
Combination Antiretroviral Therapy Is Associated With Reduction in Liver Fibrosis Scores in HIV-1-Infected Subjects. Medicine (Baltimore) (2016) 0.77
Factors associated with elevated ALT in an international HIV/HBV co-infected cohort on long-term HAART. PLoS One (2011) 0.77
Impact of hepatitis C virus on HIV response to antiretroviral therapy in Nigeria. J Acquir Immune Defic Syndr (2013) 0.76
Treatment of chronic hepatitis B in the HIV-infected patient. Hopkins HIV Rep (2003) 0.75
Variants in HAVCR1 gene region contribute to hepatitis C persistence in African Americans. J Infect Dis (2013) 0.75
Reply to Bradshaw and Danta. Clin Infect Dis (2013) 0.75
Genetic linkage of hepatitis B virus in peripheral blood leukocytes provides evidence for contamination. J Virol (2010) 0.75
Reply to Tsai et al. J Infect Dis (2013) 0.75
Treatment of lamivudine-resistant hepatitis B in HIV-infected persons: is adefovir dipivoxil the answer? J Hepatol (2005) 0.75
Brief Report: Highly Active Antiretroviral Therapy Mitigates Liver Disease in HIV Infection. J Acquir Immune Defic Syndr (2016) 0.75
Brief Report: HIV/HBV Coinfection is a Significant Risk Factor for Liver Fibrosis in Tanzanian HIV-Infected Adults. J Acquir Immune Defic Syndr (2017) 0.75
A Comparison of Hepatitis B Virus Infection in HIV-infected and HIV-uninfected Participants Enrolled in a Multi-National Clinical Trial: HPTN 052. J Acquir Immune Defic Syndr (2017) 0.75
HIV/HBV co-infection is a significant risk factor for liver fibrosis in Tanzanian HIV-infected adults. J Acquir Immune Defic Syndr (2017) 0.75